OVERVIEW | TEAM | NEWS

Team

An expert team of bioprocessing scientists and industry leaders who are deeply engaged in the scientific pursuit of growing a platform biotechnology company that enables next-generation biopharmaceutical manufacturing technologies to impact patients’ lives.

MANAGEMENT TEAM

Kevin Isett, PhD

Chief Executive Officer, CoFounder

bio

Adimab – Head of High Throughput Manufacturing

Merck – 10+ Years with Merck Biologics & Vaccines Research and Bioprocess R&D

Merck – Senior Engineer at Merck Bioprocess R&D, Automated & High-throughput Bioprocess Technologies

Dartmouth College, Thayer Engineering School – Merck-Sponsored Doctoral Fellow

Warren Kett, PhD

Chief Scientific Officer, CoFounder

bio

Dartmouth College, Thayer Engineering School – Senior Research Fellow

Glycan Biosciences – Co-Founder and CTO

GlycoFi (Acquired by Merck in 2006) – Senior Chemist

Tillman Gerngross, PhD

Chairman of the Board, CoFounder

bio

Adimab – Co-Founder and CEO

Alector – Co-Founder and Chairman of the Board

Arsanis – Co-Founder and President

GlycoFi (Acquired by Merck in 2006) – Co-Founder and CSO

Dartmouth College – Professor of Bioengineering and Associate Provost of the Office of Entrepreneurship and Technology Transfer

SV Life Sciences – Venture Partner

Scott Kennedy

Chief Financial Officer

bio

20+ years in executive life science finance operations

PerkinElmer

McGladrey & Pullen

University of Minnesota

Kimberly Cornwell

General Counsel

bio

Outside GC

Sanofi Pasteur

Acambis

Edwards and Angell

Boston University School of Law

Karol Lacki, PhD

VP Technology Development

bio

20+ years in developing and modeling biopharmaceutical separation technologies and manufacturing processes

Novo Nordisk A/S – Director Mathematical Modeling

GE Healthcare Life Sciences – Customer Collaboration Leader

Amersham Pharmacia Biotech – Polymer and Surface Chemistry

Grant Espie

Head of Resin Manufacturing

bio

20+ years in bioprocess chromatography and manufacturing experience

Dupont – Principal Investigator

EMD Chemicals Inc. – Technical Manager

Novasep Inc. – Engineering Manager

Nick Russell

Head of Business Development

bio

Pall Biotech (Acquired by Danaher Corporation)

Pfizer

University of Missouri

Brittany Crocco

Head of Quality

bio

Agilent Technologies – Nucleic Acid Solutions

Nitto Denko – Kinovate Life Sciences

University of the Sciences in Philadelphia

Certifications: ASQ, CMQ/OE, CQA

BOARD OF DIRECTORS

Tillman Gerngross, PhD

Co-Founder and Chairman of Avitide, Inc.

Co-Founder and Chief Executive Officer, Adimab LLC
Co-Founder and CSO, GlycoFi Inc. (acquired by Merck 2006)
Co-Founder, Chairman of Arsanis Inc. (merged with NASDAQ:XFOR in 2019)
Co-Founder, Chairman of Avitide
Co-Founder, Chairman of Alector (NASDAQ: ALEC)
Professor of Bioengineering, Dartmouth College
Venture Partner, SV Life Sciences

Kevin Isett, PhD

Co-Founder, CEO

Head of High Throughput Manufacturing, Adimab
10+ Years with Merck Biologics & Vaccines Research and Bioprocess R&D
Senior Engineer at Merck Bioprocess R&D, Automated & High-throughput Bioprocess Technologies
Dartmouth College, Thayer Engineering School: Merck-Sponsored Doctoral Fellow

Phil Ferneau, MBA, J.D.

Board Director, Avitide Inc.

Managing Director and Co-Founder, Borealis Ventures
Board Director, Compass Therapeutics
Board Director, Orbit Discovery Ltd.
Founding Executive Director, Dartmouth’s Tuck School of Business Center for Private Equity and Entrepreneurship
A.B. Dartmouth College
J.D. University of Virginia School of Law
M.B.A. Tuck School of Business at Dartmouth